Drug Profile
BLNP 010
Alternative Names: BLNP-010Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator BL-&-H
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anaphylaxis
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for clinical-Phase-Unknown development in Anaphylaxis in South Korea
- 19 Feb 2019 Clinical trials in Anaphylaxis in South Korea (unspecified route) (BL & H pipeline, February 2019)